| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-14 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-13 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
8e-13 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-12 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-11 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
4e-11 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-10 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-10 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-10 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-10 |